Thyroid Dysfunction and Its Emergencies in Pregnancy

  • Nalini I. Anand
  • Amita A. Gandhi


This chapter will address thyroid disorders and emergencies related to thyroid disorders in pregnant women. Maternal thyroid dysfunction and thyroid autoimmunity in pregnancy may be associated with obstetric and fetal outcomes. Treatment of overt maternal hyperthyroidism and overt hypothyroidism clearly improves outcomes. To date there is limited evidence that levothyroxine treatment of pregnant women with subclinical hypothyroidism, isolated hypothyroxinaemia or thyroid autoimmunity is beneficial. This endocrine condition can turn into an emergency if left ignored or untreated. The intention of this chapter is to realistically prepare us to face thyroid emergencies in critical situations many a times in ICU settings. This includes thyrotoxicosis, thyroid storm, hypothyroidism and myxoedema coma.


Thyroid Hormone Thyroid Dysfunction Subclinical Hypothyroidism Urinary Iodine Antithyroid Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mannisto T, Vaarasmaki M, Pouta A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population based cohort study. J Clin Endocrinal Metabol. 2009;94:772.CrossRefGoogle Scholar
  2. 2.
    Smallridge RC, Glinoer D, Hollowell JG, Brent G. Thyroid function inside and outside of pregnancy: what do we know and what don’t we know? Thyroid. 2005;15:54. Fig 1 Scholar
  3. 3.
    Thorpe-Beeston JG, Nicolaides KH, Snijders RJM, et al. Fetal thyroid stimulating hormone response to maternal administration of thyrotropin releasing hormone. Am J Obstet Gynecol. 1991;164:1244.CrossRefPubMedGoogle Scholar
  4. 4.
    Glinoer D, de Nayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71:276.CrossRefPubMedGoogle Scholar
  5. 5.
    Grossman M, Weintraub BD, Szkudlinski MW. Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological and therapeutic implications for the glycoprotein family. Endocr Rev. 1997;18:476.CrossRefGoogle Scholar
  6. 6.
    Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxin concentrations during early phases of development. J Clin Endocrinol Metab. 2000;160:526.Google Scholar
  7. 7.
    Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007;3(3):249.CrossRefPubMedGoogle Scholar
  8. 8.
    Thorpe-Beeston JG, Nicolaides KH, Snijders RJM, et al. Thyroid function in small for gestational age foetuses. Obstet Gynecol. 1991;77:701. Table -1 Scholar
  9. 9.
    Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ (Clin Res Ed). 2008;336(7645):663–7. doi: 10.1136/bmj.39462.709005.AE.PMC 2270981.CrossRefGoogle Scholar
  10. 10.
    Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid. 1999;9:727–33.CrossRefPubMedGoogle Scholar
  11. 11.
    Polak M, Le Gac I, Vuillard E, et al. Fetal and neonatal thyroid function in relation to maternal Graves’ disease. Best Pract Res Clin Endocrinol Metab. 2004;18:289–302.CrossRefPubMedGoogle Scholar
  12. 12.
    Luewan S, Chakkabut P, Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet. 2010;20.Google Scholar
  13. 13.
    Luton D, Le Gac I, Noel M, et al. Thyroid function during pregnancy in women with past Graves’ disease. BJOG. 2005;112(11):1565–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Gartner R. Thyroid diseases in pregnancy. Curr Opin Obstet Gynecol. 2009;21(6):501–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Patil Sisodia K, Mestman JH. Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract. 2010;16(1):118–29.CrossRefPubMedGoogle Scholar
  16. 16.
    Glinoer D, Cooper DS. The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):402–7. doi: 10.1097/MED.0b013e3283565b49.CrossRefPubMedGoogle Scholar
  17. 17.
    Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ. 2008;336(7645):663–7.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol. 2011;164(6):871–6. Epub 2011 Mar 9.CrossRefPubMedGoogle Scholar
  19. 19.
    Maguire D, et al. Hyperemesis gravidarum and gestational hyperthyroidism. Endocr Abstr. 2007;13:342.Google Scholar
  20. 20.
    Kung AWC, Jones BM. A change from stimulatory to blocking antibody activity in Graves’ disease during pregnancy. J Clin Endocrinol Metab. 1998;83:514.PubMedGoogle Scholar
  21. 21.
    Diav-Citrin O, Ornoy A. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology. 2002;65:38.CrossRefPubMedGoogle Scholar
  22. 22.
    Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al. Adverse effects of prenatal methimazole exposure. Teratology. 2001;64(5):262.CrossRefPubMedGoogle Scholar
  23. 23.
    Brent GA. Graves’ disease. N Engl J Med. 2008;358:2594.CrossRefPubMedGoogle Scholar
  24. 24.
    Helfgott SM. Weekly clinicopathological exercises: case 21–2002. N Engl J Med. 2002;347:122.CrossRefPubMedGoogle Scholar
  25. 25.
    Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995;273:808–12.CrossRefPubMedGoogle Scholar
  26. 26.
    National Academy of Clinical Biochemistry, NACB. Laboratory support for the diagnosis and monitoring of thyroid disease. Washington: National Academy of Clinical Biochemistry; 2002. p. 125.Google Scholar
  27. 27.
    Davison S, Lennard TWJ, Davison J, et al. Management of a pregnant patient with Graves’ disease complicated by thionamide induced neutropenia in the first trimester. Clin Endocrinol. 2001;54:559.CrossRefGoogle Scholar
  28. 28.
    Berg GEB, Nystrom EH, Jacobson L, et al. Radioiodine treatment of hyperthyroidism in a pregnant woman. J Nucl Med. 1998;39:357.PubMedGoogle Scholar
  29. 29.
    Berlin L. Malpractice issues in radiology: Iodine-131 and the pregnant patient. AJR Am J Roentgenol. 2001;176:869.CrossRefPubMedGoogle Scholar
  30. 30.
    Ayala C, Navarro E, Rodriguez JR, et al. Conception after iodine-131 therapy for differentiated thyroid cancer. Thyroid. 1998;8:1009.CrossRefPubMedGoogle Scholar
  31. 31.
    Casara D, Rubello D, Saladini G, et al. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations. Eur J Nucl Med. 1993;20:192.CrossRefPubMedGoogle Scholar
  32. 32.
    Weetman AP. Graves’ disease. N Engl J Med. 2000;343:1236–48 (Level III).CrossRefPubMedGoogle Scholar
  33. 33.
    Tietgens ST, Leinung MC. Thyroid storm. Med Clin North Am. 1995;79:169–84.PubMedGoogle Scholar
  34. 34.
    Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84:946–9.PubMedGoogle Scholar
  35. 35.
    Sherwen LN, Scoloveno MA, Weingarten CT. Maternity nursing: care of the childbearing family. 3rd ed. Stamford: Appleton & Lange; 1999.Google Scholar
  36. 36.
    Gabbe SG, Niebyl JR, Simpson JL. Obstetrics: normal and problem pregnancies. 3rd ed. New York: Churchill Livingstone; 1996.Google Scholar
  37. 37.
    Cunningham FG, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. Williams obstetrics. 21st ed. New York: McGraw-Hill; 2000.Google Scholar
  38. 38.
    Fisher D. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol. 1997;40:16–21.CrossRefPubMedGoogle Scholar
  39. 39.
    American College of Obstetrics and Gynecology. ACOG practice bulletin: thyroid disease in pregnancy. No. 37, August 2002. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet. 2002;79:171–80.CrossRefGoogle Scholar
  40. 40.
    Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am. 1998;27:127–49.CrossRefPubMedGoogle Scholar
  41. 41.
    Levin RM. Thyroid disease in pregnancy [on-line course]. January 15, 2001. Available at:–99/bcs.htm . Accessed 2 July 2002.
  42. 42.
    Mestman JH. Diagnosis and management of maternal and fetal thyroid disorders. Curr Opin Obstet Gynecol. 1999;11:167–75.CrossRefPubMedGoogle Scholar
  43. 43.
    Mazzaferri EL. Evaluation and management of common thyroid disorders in women. Am J Obstet Gynecol. 1997;176:507–14.CrossRefPubMedGoogle Scholar
  44. 44.
    Ecker JL, Musci TJ. Treatment of thyroid disease in pregnancy. Obstet Gynecol Clin North Am. 1997;24:575–89.CrossRefPubMedGoogle Scholar
  45. 45.
  46. 46.
    Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593–646. doi: 10.1089/thy.2010.0417.CrossRefPubMedGoogle Scholar
  47. 47.
    Fatourechi V. Upper limit of normal serum thyroid-stimulating hormone: a moving and now an aging target? J Clin Endocrinol Metab. 2007;92(12):4560–2. doi: 10.1210/jc.2007-2285.CrossRefPubMedGoogle Scholar
  48. 48.
    Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92(12):4575–82. doi: 10.1210/jc.2007-1499.CrossRefPubMedGoogle Scholar
  49. 49.
    Galofré JC, Frühbeck G, Salvador J. Obesity and thyroid function: pathophysiological and therapeutic implications. Hot Thyroidal. 6/10, Online ISSN: 2075–2202, p 7.Google Scholar
  50. 50.
    Brabant G, Prank K, Ranft U, Schuermeyer Th, Wagner TOF, Hauser H, Kummer B, Feistner H, Hesch RD, and von zur Mühlen A. Physiologic regulation of circadian and pulsatile thyrotropin secretion in normal men and women. J Clin Endocrinol Metab. 2013:70(2). doi: 10.1210\jcem-70-2-403.Google Scholar
  51. 51.
    Mitchell AL, Pearce SH. How should we treat patients with low serum thyrotropin concentrations? Clin Endocrinol (Oxf). 2010;72(3):292–6. doi: 10.1111/j.1365-2265.2009.03694.x.CrossRefGoogle Scholar
  52. 52.
    Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35. doi: 10.1161/CIRCULATIONAHA.106.678326.CrossRefPubMedGoogle Scholar
  53. 53.
    Wartofsky L. Management of subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011;96(1):59–61. doi: 10.1210/jc.2010-2409.CrossRefPubMedGoogle Scholar
  54. 54.
    American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy. Practice Bulletin No. 37. London: COLLEGE Publication; 2002.Google Scholar
  55. 55.
    Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63.CrossRefPubMedGoogle Scholar
  56. 56.
    Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos RJ, Pulkkinen A, Mitchell ML. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf). 1991;35(1):41–6. doi: 10.1111/j.1365-2265.1991.tb03494.x.CrossRefGoogle Scholar
  57. 57.
    Mandel SJ. Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: maternal aspects. Best Pract Res Clin Endocrinol Metab. 2004;18(2):213–24. doi: 10.1016/j.beem.2004.03.006.CrossRefPubMedGoogle Scholar
  58. 58.
    Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, Kinthaert J, Robijn C, Grun JP, de Nayer P. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab. 1991;73(2):421–7. doi: 10.1210/jcem-73-2-421.PMID 1906897.CrossRefPubMedGoogle Scholar
  59. 59.
    Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol. 1988;72(1):108–12.PubMedGoogle Scholar
  60. 60.
    Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, Cunningham FG. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105(2):239–45. doi: 10.1097/01.AOG.0000152345.99421.22.PMID 15684146.CrossRefPubMedGoogle Scholar
  61. 61.
    Stagnaro-Green A, Chen X, Bogden JD, Davies TF, Scholl TO. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid: Off J Am Thyroid Assoc. 2005;15(4):351–7. doi: 10.1089/thy.2005.15.351.PMID 15876159.CrossRefGoogle Scholar
  62. 62.
    Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi DH, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91(7):2587–91. doi: 10.1210/jc.2005-1603.CrossRefPubMedGoogle Scholar
  63. 63.
    Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O’Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549–55. doi: 10.1056/NEJM199908193410801.CrossRefPubMedGoogle Scholar
  64. 64.
    Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf). 2003;59(3):282–8. doi: 10.1046/j.1365-2265.2003.01822.x.CrossRefGoogle Scholar
  65. 65.
    Pop VJ, de Vries E, van Baar AL, Waelkens JJ, de Rooy HA, Horsten M, Donkers MM, Komproe IH, van Son MM, Vader HL. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab. 1995;80(12):3561–6. doi: 10.1210/jcem.80.12.8530599.CrossRefPubMedGoogle Scholar
  66. 66.
    Casey BM, Dashe JS, Spong CY, McIntire DD, Leveno KJ, Cunningham GF. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol. 2007;109(5):1129–35. doi: 10.1097/01.AOG.0000262054.03531.24.CrossRefPubMedGoogle Scholar
  67. 67.
    Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, Luthy D, Gross S, Bianchi DW, D’Alton ME. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112(1):85–92. doi: 10.1097/AOG.0b013e3181788dd7.CrossRefPubMedGoogle Scholar
  68. 68.
    Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007;92(8 Suppl):S1–47. doi: 10.1210/jc.2007-0141.PMID 17948378.CrossRefPubMedGoogle Scholar
  69. 69.
    Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Tournaye H, Haentjens P. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update. 2013;19(3):251–8. doi: 10.1093/humupd/dms052.CrossRefPubMedGoogle Scholar
  70. 70.
    Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf). 1999;50(2):149–55.CrossRefGoogle Scholar
  71. 71.
    Stagnaro-Green A, Chen X, Bogden JD, Davies TF, Scholl TO. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid. 2005;15(4):351–7.CrossRefPubMedGoogle Scholar
  72. 72.
    Dhanwal DK, Prasad S, Agarwal AK, Dixit V, Banerjee AK. High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India. Indian J Endocrinol Metab. 2013;17(2):281–4.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65–71.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Steingold KA, Matt DW, DeZiegler D, Sealey JE, Fratkin M, Reznikov S. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. J Clin Endocrinol Metab. 1991;73(2):275–80.CrossRefPubMedGoogle Scholar
  75. 75.
    Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;7(3):284–301.CrossRefPubMedGoogle Scholar
  76. 76.
    Ongphiphadhanakul B, Fang SL, Tang KT, Patwardhan NA, Braverman LE. Tumor necrosis factor-alpha decreases thyrotropin-induced 5′-deiodinase activity in FRTL-5 thyroid cells. Eur J Endocrinol. 1994;130(5):502–7.CrossRefPubMedGoogle Scholar
  77. 77.
    Yeum CH, Kim SW, Kim NH, Choi KC, Lee J. Increased expression of aquaporin water channels in hypothyroid rat kidney. Pharmacol Res. 2002;46(1):85–8.CrossRefPubMedGoogle Scholar
  78. 78.
    Samuels MH. Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr Opin Endocrinol Diabetes Obes. 2008;15(5):429–33.CrossRefPubMedGoogle Scholar
  79. 79.
    Gharib H, Cobin RH, Dickey RA. Subclinical hypothyroidism during pregnancy: position statement from the American Association of Clinical Endocrinologists. Endocr Pract. 1999;5(6):367–8.Google Scholar
  80. 80.
    Baisier WV, Hertoghe J, Eeckhaut W. Thyroid insufficiency. Is TSH measurement the only diagnostic tool? J Nutr Environ Med. 2000;10(2):105–13.CrossRefGoogle Scholar
  81. 81.
    Christ-Crain M, Meier C, Huber PR, Staub JJ, Muller B. Effect of l-thyroxine replacement therapy on surrogate markers of skeletal and cardiac function in subclinical hypothyroidism. Endocrinologist. 2004;14(3):161–6.CrossRefGoogle Scholar
  82. 82.
    Wilson KL, Casey BM, McIntire DD, Halvorson LM, Cunningham FG. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 2012;119(2 Pt 1):315–20.CrossRefPubMedGoogle Scholar
  83. 83.
    Wier FA, Farley CL. Clinical controversies in screening women for thyroid disorders during pregnancy. J Midwifery Womens Health. 2006;51(3):152–8.CrossRefPubMedGoogle Scholar
  84. 84.
    Stagnaro-Green A. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab. 2004;18(2):303–16. doi: 10.1016/j.beem.2004.03.008.CrossRefPubMedGoogle Scholar
  85. 85.
    van der Zanden M, Hop-de Groot RJ, Sweep FC, Ross HA, den Heijer M, Spaanderman ME. Subclinical hypothyroidism after vascular complicated pregnancy. Hypertens Pregnancy. 2013;32(1):1–10.CrossRefPubMedGoogle Scholar
  86. 86.
    Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al.; American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081–125.Google Scholar
  87. 87.
  88. 88.
    Nicoloff JT, LoPresti JS. Myxedema coma. A form of decompensated hypothyroidism. Endocrinol Metab Clin North Am. 1993;22(2):279–90.PubMedGoogle Scholar
  89. 89.
    Rehman SU, Cope DW, Senseney AD, et al. Thyroid disorders in elderly patients. South Med J. 2005;98(5):543–9.CrossRefPubMedGoogle Scholar
  90. 90.
    Yamamoto T, Fukuyama J, Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid. 1999;9(12):1167–74.CrossRefPubMedGoogle Scholar
  91. 91.
    Hylander B, Rosenqvist U. Treatment of myxoedema coma – factors associated with fatal outcome. Acta Endocrinol (Copenh). 1985;108(1):65–71.Google Scholar
  92. 92.
    Rodríguez I, Fluiters E, Pérez-Méndez LF, et al. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180(2):347–50.CrossRefPubMedGoogle Scholar
  93. 93.
    Jordan RM. Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am. 1995;79(1):185–94.PubMedGoogle Scholar
  94. 94.
    Taguchi T, Iwasaki Y, Asaba K, et al. Myxedema coma and cardiac ischemia in relation to thyroid hormone replacement therapy in a 38-year-old Japanese woman. Clin Ther. 2007;29(12):2710–4.CrossRefPubMedGoogle Scholar
  95. 95.
    Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev. 2001;22(5):605–30. doi: 10.1210/er.22.5.605.CrossRefPubMedGoogle Scholar
  96. 96.
    Bokhari R, Bhatara VS, Bandettini F, McMillan JM. Postpartum psychosis and postpartum thyroiditis. Psychoneuroendocrinology. 1998;23(6):643–50. doi: 10.1016/S0306-4530(98)00034-1.CrossRefPubMedGoogle Scholar
  97. 97.
    Premawardhana LDKE, Parkes AB, Lazarus JH. Thyroiditis, postpartum. In: Martini L, editor. Encyclopedia of endocrine diseases. New York: Elsevier; 2004. p. 509–14. doi: 10.1016/B0-12-475570-4/01299-3.CrossRefGoogle Scholar
  98. 98.
  99. 99.
    Stagnaro-Green A. Recognizing, understanding, and treating postpartum thyroiditis. Endocrinol Metab Clin N Am. 2000;29(2):417–30. doi: 10.1016/S0889-8529(05)70140-7.CrossRefGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of Obstetrics and GynaecologyM. P. Shah Govt. Medical College and HospitalJamnagarIndia
  2. 2.Arihant Women’s HospitalVice President FOGSIAhmedabadIndia

Personalised recommendations